BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 21600223)

  • 1. COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer.
    Liu H; Xiao J; Yang Y; Liu Y; Ma R; Li Y; Deng F; Zhang Y
    Microvasc Res; 2011 Sep; 82(2):131-40. PubMed ID: 21600223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COX-2-mediated regulation of VEGF-C in association with lymphangiogenesis and lymph node metastasis in lung cancer.
    Liu H; Yang Y; Xiao J; Lv Y; Liu Y; Yang H; Zhao L
    Anat Rec (Hoboken); 2010 Nov; 293(11):1838-46. PubMed ID: 20830783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
    Zhang XH; Huang DP; Guo GL; Chen GR; Zhang HX; Wan L; Chen SY
    BMC Cancer; 2008 Jan; 8():4. PubMed ID: 18190720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer.
    Di JM; Zhou J; Zhou XL; Gao X; Shao CQ; Pang J; Sun QP; Zhang Y; Ruan XX
    Arch Med Res; 2009 May; 40(4):268-75. PubMed ID: 19608016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancer.
    Bhattacharjee RN; Timoshenko AV; Cai J; Lala PK
    Cancer Sci; 2010 Sep; 101(9):2026-32. PubMed ID: 20608938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer.
    Schoppmann SF; Fenzl A; Schindl M; Bachleitner-Hofmann T; Nagy K; Gnant M; Horvat R; Jakesz R; Birner P
    Breast Cancer Res Treat; 2006 Sep; 99(2):135-41. PubMed ID: 16555123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via VEGF-C.
    Liu H; Yang Y; Xiao J; Lv Y; Liu Y; Yang H; Zhao L
    Anat Rec (Hoboken); 2009 Oct; 292(10):1577-83. PubMed ID: 19685508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B; Zhang Y; Luo G; Li L; Zhang J
    Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [COX- 2 expression in gastric cancer and its relationship with lymphangiogenesis and lymph node metastasis].
    Zhang J; Ji J; Yuan F; Yan C; Yu YY; Liu BY; Zhu ZG; Yin HR; Lin YZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Jul; 8(4):348-51. PubMed ID: 16167260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
    Miyahara M; Tanuma J; Sugihara K; Semba I
    Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
    Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
    Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relation of lymphatic microvessel density detected by monoclonal antibody D2-40 with VEGF-C expression in breast cancer].
    Xie XD; Qu SX; Zheng ZD; Song FL; Liu DW
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):356-60. PubMed ID: 18953835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of cyclooxygenase-2 on lymphangiogenesis in breast cancer].
    Guo GL; Yang GL; Li ZY; You J; Yang K; Huang DP; Hu XQ; Zhang XH
    Zhonghua Wai Ke Za Zhi; 2008 Jan; 46(2):132-5. PubMed ID: 18509974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of detection on lymphatic microvessel, lymphatic microvessel density and vascular endothelial growth factor-C in patients with colorectal carcinoma].
    Fan YZ; Li GM; Huang GP; Li XP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):477-82. PubMed ID: 17143789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of vascular endothelial growth factors (VEGF)-A, -C and -D and their prognostic significance and relationship with angio- and lymphangiogenesis in gastric cancer].
    Wang XL; Ai ZS; Fang JP; Tang RY; Chen XM
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):837-43. PubMed ID: 19173829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
    Suzuki K; Morita T; Tokue A
    Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma.
    Niki T; Iba S; Tokunou M; Yamada T; Matsuno Y; Hirohashi S
    Clin Cancer Res; 2000 Jun; 6(6):2431-9. PubMed ID: 10873096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer.
    Hashimoto I; Kodama J; Seki N; Hongo A; Yoshinouchi M; Okuda H; Kudo T
    Br J Cancer; 2001 Jul; 85(1):93-7. PubMed ID: 11437408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
    Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.